Showing results (171-180 of 280) with videos related to
Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|September 14, 2010
Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivoIlkka Liikanen, João D Dias, Petri Nokisalmi, et al.International Journal of Cancer|July 1, 2014
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcomaMikko Siurala, Simona Bramante, Lotta Vassilev, et al.Molecular Therapy Oncolytics|September 15, 2016
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunityMari Hirvinen, Cristian Capasso, Kilian Guse, et al.Journal of the National Cancer Institute|May 16, 2002
In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirusAkseli Hemminki, Kurt R Zinn, Bin Liu, et al.Frontiers in Immunology|June 4, 2021
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor ControlDafne C A Quixabeira, Sadia Zafar, Joao M Santos, et al.Cancers|September 30, 2020
Cancer Predisposition Genes in Cancer-Free FamiliesGuoqiao Zheng, Calogerina Catalano, Obul Reddy Bandapalli, et al.Molecular Therapy Oncolytics|December 21, 2018
Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic AdenovirusRiikka Havunen, João M Santos, Suvi Sorsa, et al.Journal for Immunotherapy of Cancer|February 23, 2022
Oncolytic adenovirus decreases the proportion of TIM-3<sup>+</sup> subset of tumor-infiltrating CD8<sup>+</sup> T cells with correlation to improved survival in patients with cancerIlkka Liikanen, Saru Basnet, Dafne C A Quixabeira, et al.Diseases (Basel, Switzerland)|August 23, 2022
Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian CancersCamilla Heiniö, James Clubb, Tatiana Kudling, et al.International Journal of Cancer|August 12, 2011
Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancerLotta Kangasniemi, Suvi Parviainen, Tommi Pisto, et al.Pageof 28